Shan Dong Kexing Bioproducts Co.,Ltd. Posted 58 Million Yuan Net Loss in First Three Quarters of 2022

Shan Dong Kexing Bioproducts Co.,Ltd. (科兴生物制药股份有限公司) (688136.SH) reported a net loss of 58 million yuan in the first three quarters of 2022, reversing a net profit of 75.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 944 million yuan in revenue, up 5.3% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 40.7%.